The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.5K Targets. Of those, 1.4M data for 679K Compounds and 4.6K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

8 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Irreversible inhibition of type I dehydroquinase by substrates for type II dehydroquinase.EBI
University Chemical Laboratory
A prodrug approach for improving antituberculosis activity of potent Mycobacterium tuberculosis type II dehydroquinase inhibitors.EBI
Universidad De Santiago De Compostela
Synthesis and biological evaluation of new nanomolar competitive inhibitors of Helicobacter pylori type II dehydroquinase. Structural details of the role of the aromatic moieties with essential residues.EBI
Universidad De Santiago De Compostela
Crystal structures of Helicobacter pylori type II dehydroquinase inhibitor complexes: new directions for inhibitor design.EBI
University of Glasgow
Structure-based design, synthesis, and biological evaluation of inhibitors of Mycobacterium tuberculosis type II dehydroquinase.EBI
Universidad De Santiago De Compostela
Parallel solid-phase synthesis and evaluation of inhibitors of Streptomyces coelicolor type II dehydroquinase.EBI
Universidad De Santiago De Compostela
Exploring the water-binding pocket of the type II dehydroquinase enzyme in the structure-based design of inhibitors.EBI
Universidad De Santiago De Compostela
In silico fragment-based drug design with SEED.EBI
University of Z£Rich